Literature DB >> 21331030

Genomics: Drugs, diabetes and cancer.

Morris J Birnbaum, Reuben J Shaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331030      PMCID: PMC4237313          DOI: 10.1038/470338a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

Authors:  Reuben J Shaw; Katja A Lamia; Debbie Vasquez; Seung-Hoi Koo; Nabeel Bardeesy; Ronald A Depinho; Marc Montminy; Lewis C Cantley
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

2.  An unusual form of diabetes mellitus in ataxia telangiectasia.

Authors:  D S Schalch; D E McFarlin; M H Barlow
Journal:  N Engl J Med       Date:  1970-06-18       Impact factor: 91.245

Review 3.  An energetic tale of AMPK-independent effects of metformin.

Authors:  Russell A Miller; Morris J Birnbaum
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

4.  Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.

Authors:  D Q Yang; M B Kastan
Journal:  Nat Cell Biol       Date:  2000-12       Impact factor: 28.824

5.  ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.

Authors:  Jochen G Schneider; Brian N Finck; Jie Ren; Kara N Standley; Masatoshi Takagi; Kirsteen H Maclean; Carlos Bernal-Mizrachi; Anthony J Muslin; Michael B Kastan; Clay F Semenkovich
Journal:  Cell Metab       Date:  2006-11       Impact factor: 27.287

6.  Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.

Authors:  Gopal P Sapkota; Maria Deak; Agnieszka Kieloch; Nick Morrice; Aaron A Goodarzi; Carl Smythe; Yosef Shiloh; Susan P Lees-Miller; Dario R Alessi
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

8.  Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.

Authors:  Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Kathryn G Ewens; Richard S Spielman; Phyllis C Leppert; Evan R Myers
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

9.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

10.  Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.

Authors:  Kaixin Zhou; Celine Bellenguez; Chris C A Spencer; Amanda J Bennett; Ruth L Coleman; Roger Tavendale; Simon A Hawley; Louise A Donnelly; Chris Schofield; Christopher J Groves; Lindsay Burch; Fiona Carr; Amy Strange; Colin Freeman; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Serge Dronov; Audrey Duncanson; Sarah Edkins; Emma Gray; Sarah Hunt; Janusz Jankowski; Cordelia Langford; Hugh S Markus; Christopher G Mathew; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Nilesh J Samani; Richard Trembath; Ananth C Viswanathan; Nicholas W Wood; Lorna W Harries; Andrew T Hattersley; Alex S F Doney; Helen Colhoun; Andrew D Morris; Calum Sutherland; D Grahame Hardie; Leena Peltonen; Mark I McCarthy; Rury R Holman; Colin N A Palmer; Peter Donnelly; Ewan R Pearson
Journal:  Nat Genet       Date:  2010-12-26       Impact factor: 38.330

View more
  14 in total

1.  Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.

Authors:  Xuxian Xiao; Qiongqiong He; Changming Lu; Kaitlin D Werle; Rui-Xun Zhao; Jianfeng Chen; Ben C Davis; Rutao Cui; Jiyong Liang; Zhi-Xiang Xu
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

2.  The association and joint effect of serum cholesterol, glycemic status with the risk of incident cancer among middle-aged and elderly population in china cardiometabolic disease and cancer cohort (4C)-study.

Authors:  Mian Li; Jieli Lu; Jing Fu; Qin Wan; Tiange Wang; Yanan Huo; Yu Xu; Min Xu; Zhiyun Zhao; Yuhong Chen; Shuangyuan Wang; Guijun Qin; Yingfen Qin; Ruying Hu; Xulei Tang; Guixia Wang; Feixia Shen; Zuojie Luo; Li Chen; Qing Su; Xuefeng Yu; Li Yan; Gang Chen; Zhengnan Gao; Yinfei Zhang; Chao Liu; Youmin Wang; Shengli Wu; Tao Yang; Qiang Li; Yiming Mu; Jiajun Zhao; Lulu Chen; Lixin Shi; Guang Ning; Yufang Bi; Hongyang Wang; Weiqing Wang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 3.  Insulin signaling and insulin resistance.

Authors:  Elmus G Beale
Journal:  J Investig Med       Date:  2013-01       Impact factor: 2.895

4.  Gerosuppressant metformin: less is more.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Luciano Vellon; Jorge Joven; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

Review 5.  Metformin: multi-faceted protection against cancer.

Authors:  Sonia Del Barco; Alejandro Vazquez-Martin; Sílvia Cufí; Cristina Oliveras-Ferraros; Joaquim Bosch-Barrera; Jorge Joven; Begoña Martin-Castillo; Javier A Menendez
Journal:  Oncotarget       Date:  2011-12

Review 6.  Recent progress in targeting cancer.

Authors:  Zoya N Demidenko; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

Review 7.  Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Begoña Martin-Castillo; Jorge Joven; Luciano Vellon; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-11       Impact factor: 5.682

Review 8.  Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Yan-Gang Wang; Peng Wang; Bin Wang; Zheng-Ju Fu; Wen-Juan Zhao; Sheng-Li Yan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

9.  Chemoprevention of prostate cancer: soy isoflavones and curcumin.

Authors:  Shigeo Horie
Journal:  Korean J Urol       Date:  2012-10-19

10.  TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations.

Authors:  Fang Hua; Ke Li; Jiao-Jiao Yu; Xiao-Xi Lv; Jun Yan; Xiao-Wei Zhang; Wei Sun; Heng Lin; Shuang Shang; Feng Wang; Bing Cui; Rong Mu; Bo Huang; Jian-Dong Jiang; Zhuo-Wei Hu
Journal:  Nat Commun       Date:  2015-08-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.